Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Amezinium methylsulfate (Lu-1631) has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | In stock | $ 48.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 50.00 |
Description | Amezinium methylsulfate (Lu-1631) has multiple mechanisms, including stimulation of alpha and beta-1 receptors and inhibition of noradrenaline and tyramine uptake. |
In vivo | In 5 patients with multiple system atrophy, administration of 15 mg/day of amezinium metilsulfate, an adrenergic agent, during 6 months for the treatment of postural hypotension exacerbated post-micturition residuals as compared to that before treatment (178 ml versus 113 ml for a change of 37 %) [1]. The reduction ratio of FTBF was significantly increased by amezimium [placebo, 75.9%; amezinium, 85.1%; midodrine, 78.1%]. The infusion rate of noradrenaline producing a half-maximum venoconstriction was significantly decreased by amezinium (placebo, 40.6 ng/min; amezinium, 21.0 ng/min) [2]. |
Synonyms | Amezinium metilsulfate, Amezinium (methylsulfate), Lu-1631 |
Molecular Weight | 313.33 |
Formula | C12H15N3O5S |
CAS No. | 30578-37-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (159.58 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Amezinium methylsulfate 30578-37-1 GPCR/G Protein Neuroscience Adrenergic Receptor Amezinium metilsulfate Lu 1631 inhibit Lu1631 methylsulfate Beta Receptor Amezinium (methylsulfate) Inhibitor Amezinium Lu-1631 inhibitor